Cubist Systematic Strategies, LLC Ptc Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.1 Billion
Q4 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 141,410 shares of PTCT stock, worth $7.67 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

141,410

Previous 60,674 133.07%

Holding current value

$7.67 Million

Previous $2.25 Million 183.56%

% of portfolio

0.04%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$34.99 - $52.07 $2.82 Million - $4.2 Million	80,736 Added 133.07%	141,410 $6.38 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $12.7 Million - $15.7 Million	-417,767 Reduced 87.32%	60,674 $2.25 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $2.99 Million - $4.86 Million	121,139 Added 33.9%	478,441 $14.6 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $3.4 Million - $4.5 Million	140,894 Added 65.11%	357,302 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $3.91 Million - $6.36 Million	216,408 New	216,408 $5.96 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $900,031 - $1.32 Million	22,278 Added 153.41%	36,800 $1.5 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $450,860 - $577,280	-11,815 Reduced 44.86%	14,522 $703,000
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $3.06 Million - $5 Million	-91,273 Reduced 77.61%	26,337 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $3.79 Million - $4.88 Million	90,540 Added 334.47%	117,610 $5.9 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $66,278 - $117,100	-2,589 Reduced 8.73%	27,070 $1.08 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $413,292 - $553,040	12,400 Added 71.85%	29,659 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $756,951 - $896,097	-21,407 Reduced 55.36%	17,259 $687,000
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $471,618 - $570,121	-12,743 Reduced 24.79%	38,666 $1.44 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $688,299 - $895,423	18,137 Added 54.51%	51,409 $2.17 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $533,426 - $785,550	-11,398 Reduced 25.52%	33,272 $1.58 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $1.19 Million - $1.68 Million	24,765 Added 124.42%	44,670 $2.73 Million
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $863,017 - $1.08 Million	19,005 Added 2111.67%	19,905 $931,000
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $35,026 - $45,248	823 Added 1068.83%	900 $46,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $874,734 - $1.6 Million	-27,023 Reduced 99.72%	77 $3,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $723,725 - $1.12 Million	22,462 Added 484.3%	27,100 $1.3 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $1.48 Million - $2.1 Million	-43,635 Reduced 90.39%	4,638 $157,000
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $1.61 Million - $2.05 Million	45,473 Added 1624.04%	48,273 $2.17 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $28,090 - $39,490	1,000 Added 55.56%	2,800 $105,000
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $8,591 - $13,394	-288 Reduced 13.79%	1,800 $62,000
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $70,783 - $99,743	2,088 New	2,088 $98,000
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $419,064 - $780,731	-16,306 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $284,702 - $531,412	16,306 New	16,306 $441,000
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $70,582 - $97,389	-4,662 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $78,368 - $100,745	4,662	4,662 $93,000

Others Institutions Holding PTCT

# of Institutions

259

Shares Held

72.7M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.88B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Ptc Therapeutics, Inc. Transaction History